TY - CHAP U1 - Konferenzveröffentlichung A1 - Neidhardt, Jonathan Philipp A1 - Fronczek, David Norman A1 - Jahnke, Thomas A1 - Danner, Timo A1 - Horstmann, Birger A1 - Bessler, Wolfgang G. T1 - A Flexible Framework for Modeling Multiple Solid, Liquid and Gaseous Phases in Batteries and Fuel Cells T2 - Journal of The Electrochemical Society N2 - Multi-phase management is crucial for performance and durability of electrochemical cells such as batteries and fuel cells. In this paper we present a generic framework for describing the two-dimensional spatiotemporal evolution of gaseous, liquid and solid phases, as well as their interdependence with interfacial (electro-)chemistry and microstructure in a continuum description. The modeling domain consists of up to seven layers (current collectors, channels, electrodes, separator/membrane), each of which can consist of an arbitrary number of bulk phases (gas, liquid, solid) and connecting interfaces (two-phase or multi-phase boundaries). Bulk and interfacial chemistry is described using global or elementary kinetic reactions. Multi-phase management is coupled to chemistry and to mass and charge transport within bulk phases. The functionality and flexibility of this framework is demonstrated using four application areas in the context of post-lithium-ion batteries and fuel cells, that is, lithium-sulfur (Li-S) cells, lithium-oxygen (Li-O) cells, solid oxide fuel cells (SOFC) and polymer electrolyte membrane fuel cells (PEFC). The results are compared to models available in literature and properties of the generic framework are discussed. KW - Brennstoffzelle KW - Batterie KW - Modell KW - Rahmen Y1 - 2012 UR - https://elib.dlr.de/76228/1/Neidhardt_et_al_2012_MODVAL9.pdf SN - 0013-4651 SS - 0013-4651 U6 - https://doi.org/10.1149/2.023209jes DO - https://doi.org/10.1149/2.023209jes N1 - 9th Symposium on Fuel Cell and Battery Modeling and Experimental Validation (ModVal 9), Campus Sursee, Switzerland, April 2-4, 2012 VL - 159 IS - 9 SP - A1528 EP - A1542 ER - TY - JOUR U1 - Zeitschriftenartikel, wissenschaftlich - begutachtet (reviewed) A1 - Mensonides-Harsema, Marguérite M. A1 - Otte, Andreas T1 - European regulatory framework on the use and development of pharmaceuticals and radiopharmaceuticals for pediatrics JF - Hellenic Journal of Nuclear Medicine N2 - A survey in 2000 revealed that only about 30% of the prescriptions in the European pediatric population were on the basis of evidence-based medicine (EbM). Less for radiopharmaceuticals and principally for diagnostics, radiologists throughout Europe are referred to the pediatric guidelines of the European Association of Nuclear Medicine (EANM), as none of the frequently used tracers have been evaluated in clinical trials in the different pediatric subgroups. Following a resolution to address the lack of EbM in children, the European Commission published the Pediatric Regulation EC 1901/2006 and its amendment EC 1902/2006, effective from 2007. This regulation foresees the development of evidence-based medicine in the pediatric population. This is effected through a set of principles like the mandatory pediatric investigation plan (PIP) to be included with the market authorization application (MAA), and the pediatric use market authorization (PUMA) for off-patent pharmaceuticals, and to a very small part radiopharmaceuticals with funding possibilities for pediatric-specific research through the 7th Framework Programme (7FP) of the European Union. KW - Kinderheilkunde KW - Pharmazie KW - Europa KW - Rahmen Y1 - 2011 UR - https://www.nuclmed.gr/wp/wp-content/uploads/2017/03/14-1.pdf SN - 1790-5427 SS - 1790-5427 PM - 21512665 VL - 14 IS - 1 SP - 43 EP - 48 ER -